ATT Wins FDA nod for Foamless Negative Pressure Wound Therapy System

ATT wins FDA nod for foamless negative pressure wound therapy system Applied Tissue Technologies LLC (ATT) has won U.S. FDA clearance for a negative pressure wound therapy (NPWT) system that eliminates foam as a potential impediment to complete wound healing. ATT CEO Michael Broomhead said negative pressure wound therapy is…

Continue ReadingATT Wins FDA nod for Foamless Negative Pressure Wound Therapy System

Novel Embossed Negative Pressure Wound Therapy Dressing Demonstrates Equal Efficacy to Traditional Foam and Gauze Devices in Independently Monitored GLP Comparison Study

Applied Tissue Technologies (ATT), an advanced wound care company, announced the publication of a peer reviewed study in Plastic and Reconstructive Surgery Journal®, "Study Comparing Platform Wound Dressing (PWD® ), a Negative-Pressure Device without a Filler, with Three Conventional Negative-Pressure Wound Therapy Systems in the Treatment of Excisional and Incisional Wounds".  Click…

Continue ReadingNovel Embossed Negative Pressure Wound Therapy Dressing Demonstrates Equal Efficacy to Traditional Foam and Gauze Devices in Independently Monitored GLP Comparison Study

FDA Issues 510(k) Clearance to Applied Tissue Technologies’ Platform Wound Dressing (PWD®), A New Negative Pressure Wound Therapy System Without Foam or Gauze

Applied Tissue Technologies (ATT), an advanced wound care company, announced US FDA 510(k) clearance of its Negative Pressure Wound Therapy product, the Platform Wound Dressing (PWD®). Classified by the FDA as a class II device, the patented PWD represents the first-of-its-kind embossed negative pressure wound therapy (NPWT) device to be used without…

Continue ReadingFDA Issues 510(k) Clearance to Applied Tissue Technologies’ Platform Wound Dressing (PWD®), A New Negative Pressure Wound Therapy System Without Foam or Gauze

Wound therapy device wins FDA authorization – Medtechdive.com

"Now, ATT wants to render the foam versus gauze debate irrelevant for many wounds by introducing a device that has built-in filler material. ATT's Platform Wound Dressing (PWD) features a permanently embossed impermeable membrane. This serves as both the membrane and filler material, enabling healthcare professionals to perform NPWT without…

Continue ReadingWound therapy device wins FDA authorization – Medtechdive.com

Xpansion MicroAutografting kit is now available in Israel exclusively through Tzur Medical

Applied Tissue Technologies has reached an agreement that will provide Tzur Medical with exclusive distribution of the Xpansion MicroAutografting kit in Israel.  We are excited to begin this partnership with Tzur medical and provide this enabling technology to the practitioners within Israel. Xpansion® Micro-autografting is a sterile kit for the harvesting,…

Continue ReadingXpansion MicroAutografting kit is now available in Israel exclusively through Tzur Medical

Platform Wound Device wins Oral presentation at the Wound Healing Society Meeting in San Diego, April 2017. Topical Delivery of an antibiotic enclosed in the PWD on a full thickness burn demonstrates penetration of the eschar in a porcine model.

The drug delivery enabling technology of the PWD will be demonstrated at the American Burn Association meeting on March 21-24, 2017 in Boston, MA.  Dr. Kristo Nuutila will present the poster entitled: "Topical minocycline hydrogel penetrates the eschar of a full-thickness burn and significantly reduces subeschar tissue biopsy bacterial counts."…

Continue ReadingPlatform Wound Device wins Oral presentation at the Wound Healing Society Meeting in San Diego, April 2017. Topical Delivery of an antibiotic enclosed in the PWD on a full thickness burn demonstrates penetration of the eschar in a porcine model.

Platform Wound Device/ New Breakthrough in NPWT to be presented at SAWC Poster Session April 2017. Embossed device eliminates the need for foam or gauze wound filler when treating wounds with Negative Pressure Wound Therapy

Dr. Elof Eriksson M.D. Ph.D. will present a poster entitled, “A New Negative Pressure Wound Therapy Device without Foam or Gauze” on Friday, April 7, 2017 from 7:15 p.m.–8:45 p.m.  Additional information on the SAWC and WHS meeting can be found at http://www.sawc.net/spring/ .  The meeting will be held at…

Continue ReadingPlatform Wound Device/ New Breakthrough in NPWT to be presented at SAWC Poster Session April 2017. Embossed device eliminates the need for foam or gauze wound filler when treating wounds with Negative Pressure Wound Therapy

Xpansion MicroAutografting kit is now available in Australia and New Zealand through Ozmedix

Applied Tissue Technologies has reached an agreement that will provide Ozmedix with exclusive distribution of the Xpansion MicroAutografting kit in Australia and New Zealand. Xpansion® Micro-autografting is a sterile kit for the harvesting, mechanical preparation and application of skin autografts without the need for an operating theatre. Ideal for any chronic…

Continue ReadingXpansion MicroAutografting kit is now available in Australia and New Zealand through Ozmedix

Xpansion MicroAutografting to be presented at SAWC Poster Session in San Diego, April 2017

Dr. Debora Sanches Pinto of Sao Paulo University Hospital, Sao Paulo, Brazil will present a poster entitled, "Outpatient Minced split-thickness skin grafts for burn wounds and venous ulcers" on Friday, April 7, 2017 from 7:15 p.m.–8:45 p.m.  Additional information on the SAWC and WHS meeting can be found at http://www.sawc.net/spring/…

Continue ReadingXpansion MicroAutografting to be presented at SAWC Poster Session in San Diego, April 2017